2011
DOI: 10.1016/j.ajpath.2010.11.054
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Transforming Growth Factor β Worsens Elastin Degradation in a Murine Model of Kawasaki Disease

Abstract: Kawasaki disease (KD) is an acute inflammatory illness marked by coronary arteritis. However, the factors increasing susceptibility to coronary artery lesions are unknown. Because transforming growth factor (TGF) ␤ increases elastin synthesis and suppresses proteolysis, we hypothesized that, in contrast to the benefit observed in aneurysms forming in those with Marfan syndrome, inhibition of TGF-␤ would worsen inflammatory-induced coronary artery lesions. By using a murine model of KD in which injection of Lac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 58 publications
0
13
0
Order By: Relevance
“…In a mouse model of coronary arteritis, TGF-β blockade resulted in increased elastin degradation associated with increased matrix metalloproteinase (MMP)-9 activity that resulted from TGF-β-mediated decrease in plasminogen activator inhibitor-1, an inhibitor of plasmin that activates MMP-9 [30]. Thus, caution must be excercised in drawing conclusions about the desirability of inhibiting TGF-β signaling in this patient population.…”
Section: Discussionmentioning
confidence: 99%
“…In a mouse model of coronary arteritis, TGF-β blockade resulted in increased elastin degradation associated with increased matrix metalloproteinase (MMP)-9 activity that resulted from TGF-β-mediated decrease in plasminogen activator inhibitor-1, an inhibitor of plasmin that activates MMP-9 [30]. Thus, caution must be excercised in drawing conclusions about the desirability of inhibiting TGF-β signaling in this patient population.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, TGFβ blockade exacerbates elastin degradation and decreases levels of elastin in medial layers of blood vessels (Alvira et al, 2011). By contrast, overexpression of a mutated, active form of TGFβ1 in animals having experimentally induced aortic aneurysms leads to reduction in the expression of elastolytic MMPs and preservation of elastic fibers in the medial layers of injured aortas (Dai et al, 2005).…”
Section: Cytokines That Promote Elastin Formationmentioning
confidence: 99%
“…Unexpectedly, non-specific blocking of TGFβ by administration of TGFβNAb worsens the cardiovascular disease in these mice. This detrimental effect is attributed to a reduction in the proteolytic inhibitor and TGFβ target molecule, plasminogen activator inhibitor-1 (PAI1), and an associated increase in matrix metalloproteinase activity (Alvira et al 2011). It is noteworthy that many detrimental effects of TGFβ-based therapy can be attributed, in major part, to the role of TGFβ signaling in autoimmunity (Fig.…”
Section: Tgfβ-based Therapies and Its Potential Complications For Carmentioning
confidence: 99%
“…It is noteworthy that many detrimental effects of TGFβ-based therapy can be attributed, in major part, to the role of TGFβ signaling in autoimmunity (Fig. 3) (Yoshimura et al 2010;Shull et al 1992;Azhar et al 2009b;Anuurad et al 2011;Alvira et al 2011;King et al 2009;Tieu et al 2009;Daugherty et al 2010;Wang et al 2010;Mallat et al 2001). Consequently, although targeting TGFβ ligands and their signaling offers hope for treating valve, aortic and myocardial and inflammatory cardiovascular complications in both syndromic and non-syndromic patients, serious concerns remain whether a non-specific preemptive blocking of TGFβ ligands aimed to treat a single cardiovascular manifestation could result in undesirable side-effects on other aspects of cardiovascular remodeling or physiology.…”
Section: Tgfβ-based Therapies and Its Potential Complications For Carmentioning
confidence: 99%